Expertise in
4
conditions

Giovanni L. Ceresoli

Cliniche Humanitas Gavazzeni
Bergamo, IT 
Expertise in
4
conditions
Cliniche Humanitas Gavazzeni
Bergamo, IT 
OverviewLocationsClinical Research

Overview

Giovanni Ceresoli practices in Bergamo, Italy. Mr. Ceresoli is highly rated in 4 conditions, according to our data. His top areas of expertise are Mesothelioma, Lung Cancer, Hydrocele, Tissue Biopsy, and Orchiectomy.

His clinical research consists of co-authoring 88 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Cliniche Humanitas Gavazzeni
Bergamo, 24125, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open-label, Randomized Phase III Study of Early Switch Maintenance vs DElayed Second-line Nivolumab in Advanced Stage Squamous Non Small-cell Lung Cancer (NSCLC) Patients After Standard First-line Platinum-based Chemotherapy - EDEN Trial
An Open-label, Randomized Phase III Study of Early Switch Maintenance vs DElayed Second-line Nivolumab in Advanced Stage Squamous Non Small-cell Lung Cancer (NSCLC) Patients After Standard First-line Platinum-based Chemotherapy - EDEN Trial
Enrollment Status: Unknown
Publish Date: October 03, 2022
Intervention Type: Other, Drug
Study Drug: Nivolumab
Study Phase: Phase 3
ATREUS Trial - A Phase II Study on the Activity of Trabectedin of Pretreated Epithelioid or Biphasic / Sarcomatoid Malignant Pleural Mesothelioma(MPM)
ATREUS Trial - A Phase II Study on the Activity of Trabectedin of Pretreated Epithelioid or Biphasic / Sarcomatoid Malignant Pleural Mesothelioma(MPM)
Enrollment Status: Completed
Publish Date: January 23, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase II Trial of Pemetrexed and Cisplatin or Carboplatin in Combination With TTFields (150 kHz) as First-line Treatment in Malignant Pleural Mesothelioma
A Phase II Trial of Pemetrexed and Cisplatin or Carboplatin in Combination With TTFields (150 kHz) as First-line Treatment in Malignant Pleural Mesothelioma
Enrollment Status: Completed
Publish Date: September 25, 2018
Intervention Type: Drug, Device
Study Phase: Phase 2
View 2 Less Clinical Trials

88 Total Publications

Pericardial Mesothelioma: Diagnostic and Therapeutic Management, a Population-Based Study in Italy.
Pericardial Mesothelioma: Diagnostic and Therapeutic Management, a Population-Based Study in Italy.
Journal: Cancers
Published: October 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ceresoli's expertise for a condition
ConditionClose
View All 18 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile